Back to Industry News
Medtech
Investor AB: A Swedish Investment Giant With Diverse Holdings
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Dagens industri
Stay updated on stories like this
Key takeaways
- The Dagens Industri data page for Investor B (INVE B) offers a concise overview of the company's financial performance and recent analyst recommendations
- The latest report indicates that Investor B has a total of 3,068,700,120 shares outstanding
- Analyst ratings, sourced from Nyhetsbyrån Direkt, are a central element of the page's content, reflecting diverse perspectives on the stock's future prospects
The Dagens Industri data page for Investor B (INVE B) offers a concise overview of the company's financial performance and recent analyst recommendations. The latest report indicates that Investor B has a total of 3,068,700,120 shares outstanding.
Analyst ratings, sourced from Nyhetsbyrån Direkt, are a central element of the page's content, reflecting diverse perspectives on the stock's future prospects. Recent updates include SEB Equities increasing its price target to 366 kronor and reaffirming a "buy" recommendation. Kepler Cheuvreux and Citi Investment Research have also raised their respective price targets.
Despite these target increases, analyst ratings vary. Kepler Cheuvreux maintains a "buy" rating, while Citi has reiterated a "sell" recommendation. Earlier in April, DNB Markets and Kepler Cheuvreux had both lowered their price targets, though both firms retained their "buy" recommendations at that time. The information on the page is supplied by Millistream and is subject to a 15-minute delay.
Related Topics
Investor ABinvestment companySwedish corporationstelecommunicationsmedtech
Never miss stories like this